ArticleCrohn's & colitis 3602021

Why Is There Low Utilization of Biosimilars in Inflammatory Bowel Disease Patients by Gastroenterology Advanced Practice Providers?

Nana Bernasko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.